journal
Journals Journal of the Royal Society o...

Journal of the Royal Society of Medicine

https://read.qxmd.com/read/38054401/is-the-1948-model-of-access-to-free-healthcare-still-appropriate-today
#41
JOURNAL ARTICLE
Peter Terence McManus
No abstract text is available yet for this article.
December 6, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38054400/1948-healthcare-still-appropriate-today
#42
JOURNAL ARTICLE
Mark Zy Tan
No abstract text is available yet for this article.
December 6, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38054392/sodium-glucose-co-transporter-2-inhibitors-and-glucagon-like-peptide-1-receptor-agonists-treatment-variable-observations-of-sequelae-on-diabetic-retinopathy
#43
LETTER
George I Varughese, Sarita Jacob
No abstract text is available yet for this article.
December 6, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38164727/from-jrsm-open
#44
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38164726/death-notices
#45
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38164725/for-more-events-and-to-book-online-please-visit-www-rsm-ac-uk-events
#46
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38164724/how-can-the-nhs-be-funded
#47
JOURNAL ARTICLE
Kamran Abbasi
No abstract text is available yet for this article.
December 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37991475/heresy-witchcraft-jean-gerson-scepticism-and-the-use-of-placebo-controls
#48
JOURNAL ARTICLE
R Kirakosian, L Möllenbrink, G Zamore, T J Kaptchuk, K Jensen
No abstract text is available yet for this article.
November 22, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37991459/paul-owren-christopher-bjerkelund-and-the-dawn-of-controlled-trials-in-norway
#49
JOURNAL ARTICLE
Magne Nylenna
No abstract text is available yet for this article.
November 22, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37991449/the-differences-and-overlaps-between-explanatory-and-pragmatic-controlled-trials-a-historical-perspective
#50
JOURNAL ARTICLE
Paul Glasziou, Robert Matthews, Isabelle Boutron, Iain Chalmers, Peter Armitage
No abstract text is available yet for this article.
November 22, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37989250/a-deathly-silence-why-has-the-number-of-people-found-decomposed-in-england-and-wales-been-rising
#51
JOURNAL ARTICLE
Lucinda Hiam, Theodore Estrin-Serlui, Danny Dorling, Martin McKee, Jon Minton
OBJECTIVES: The number of deaths occurring in private homes in England and Wales had been rising for years, increasingly rapidly from 2020. Media stories and research linked decomposing bodies found in private homes with pandemic-related social isolation. We aim to explore whether these incidents are one-offs or part of a wider trend. DESIGN: Descriptive analysis of publicly available Office for National Statistics (ONS) data. SETTING: England and Wales...
November 21, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37975723/trial-analysis-by-treatment-allocated-or-by-treatment-received-origins-of-the-intention-to-treat-principle-to-reduce-allocation-bias-part-2
#52
JOURNAL ARTICLE
I Chalmers, R Matthews, P Glasziou, I Boutron, P Armitage
No abstract text is available yet for this article.
November 17, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37971412/the-difference-in-all-cause-mortality-between-covid-19-patients-treated-with-standard-of-care-plus-placebo-and-those-treated-with-standard-of-care-alone-a-network-meta-analysis-of-randomised-controlled-trials-of-immunomodulatory-kinase-inhibitors
#53
JOURNAL ARTICLE
Ping-Tao Tseng, Bing-Syuan Zeng, Chih-Wei Hsu, Trevor Thompson, Brendon Stubbs, Po-Ren Hsueh, Kuan-Pin Su, Yen-Wen Chen, Tien-Yu Chen, Yi-Cheng Wu, Pao-Yen Lin, Andre F Carvalho, Dian-Jeng Li, Ta-Chuan Yeh, Cheuk-Kwan Sun, Yu-Shian Cheng, Yow-Ling Shiue, Chih-Sung Liang, Yu-Kang Tu
OBJECTIVES: The aim of this network meta-analysis (NMA) was to assess whether participants assigned to a placebo and standard of care (SoC) group had different major coronavirus disease 2019 (COVID-19)-related outcomes than those assigned to SoC alone. DESIGN: Frequentist model-based NMA. SETTING: We searched for randomised controlled trials (RCTs) of Janus kinase/Bruton tyrosine kinase inhibitors for the management of COVID-19. PARTICIPANTS: Patients with COVID-19 infection...
November 16, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37921538/adverse-events-after-first-and-second-doses-of-covid-19-vaccination-in-england-a-national-vaccine-surveillance-platform-self-controlled-case-series-study
#54
JOURNAL ARTICLE
Ruby Sm Tsang, Utkarsh Agrawal, Mark Joy, Rachel Byford, Chris Robertson, Sneha N Anand, William Hinton, Nikhil Mayor, Debasish Kar, John Williams, William Victor, Ashley Akbari, Declan T Bradley, Siobhan Murphy, Dermot O'Reilly, Rhiannon K Owen, Antony Chuter, Jillian Beggs, Gary Howsam, Aziz Sheikh, F D Richard Hobbs, Simon de Lusignan
OBJECTIVES: To estimate the incidence of adverse events of interest (AEIs) after receiving their first and second doses of coronavirus disease 2019 (COVID-19) vaccinations, and to report the safety profile differences between the different COVID-19 vaccines. DESIGN: We used a self-controlled case series design to estimate the relative incidence (RI) of AEIs reported to the Oxford-Royal College of General Practitioners national sentinel network. We compared the AEIs that occurred seven days before and after receiving the COVID-19 vaccinations to background levels between 1 October 2020 and 12 September 2021...
November 3, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38014896/death-notices
#55
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38014895/for-more-events-and-to-book-online-please-visit-www-rsm-ac-uk-diary
#56
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38014894/from-jrsm-open
#57
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/38014893/drift-and-doom-from-workforce-to-the-climate-crisis
#58
JOURNAL ARTICLE
Kamran Abbasi
No abstract text is available yet for this article.
November 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37905556/time-to-treat-the-climate-and-nature-crisis-as-one-indivisible-global-health-emergency
#59
EDITORIAL
Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski
No abstract text is available yet for this article.
October 31, 2023: Journal of the Royal Society of Medicine
https://read.qxmd.com/read/37905525/prevalence-of-multiple-long-term-conditions-multimorbidity-in-england-a-whole-population-study-of-over-60-million-people
#60
JOURNAL ARTICLE
Jonathan Valabhji, Emma Barron, Adrian Pratt, Nasrin Hafezparast, Rupert Dunbar-Rees, Ellie Bragan Turner, Kate Roberts, Jacqueline Mathews, Robbie Deegan, Victoria Cornelius, Jason Pickles, Gary Wainman, Chirag Bakhai, Desmond G Johnston, Edward W Gregg, Kamlesh Khunti
OBJECTIVES: To determine the prevalence of multiple long-term conditions (MLTC) at whole English population level, stratifying by age, sex, socioeconomic status and ethnicity. DESIGN: A whole population study. SETTING: Individuals registered with a general practice in England and alive on 31 March 2020. PARTICIPANTS: 60,004,883 individuals. MAIN OUTCOME MEASURES: MLTC prevalence, defined as two or more of 35 conditions derived from a number of national patient-level datasets...
October 31, 2023: Journal of the Royal Society of Medicine
journal
journal
27306
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.